Republish Our Content
Email Sign Up
Contact Us

Connect With Us:
Contact
Twitter
Facebook
RSS

Daily Edition
Special Reports
Faces of Medi-Cal
Noticias En Español
More Topics
- Aging
- Asking Never Hurts
- Audio Report
- Covid
- Health Industry
- Insurance
- Medi-Cal
- Medicare
- Mental Health
- Spotlight

Search KFF Health News

California Healthline Daily Edition

Summaries of health policy coverage from major news organizations

Tuesday, Sep 9 2008

Antitrust Waiting Period for CVS’ Acquisition of Longs Ends

CVS Caremark and Longs Drugstores announced that the waiting period, required under the Hart-Scott-Rodino Antitrust Improvements Act, for CVS' acquisition of Longs ended on Friday. In August, Longs agreed to be acquired by CVS for $2.7 billion.

"CVS Clears Antitrust Hurdle for Longs Drugs Acquisition" (East Bay Business Times, 9/8).

This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.

Recent Daily Editions

Friday, September 6
Thursday, September 5
Wednesday, September 4
Tuesday, September 3
Tuesday, August 27
Monday, August 26

From The California Health Care Foundation

CalAIM CalAIM in Focus

Explore CHCF’s collection of tools and resources aimed at helping organizations understand and implement CalAIM.

People Experiencing Homelessness Homelessness & Health Care Resource Center

Explore resources from CHCF that help health care, homeless services providers, government, and other systems work together so people are housed and healthy.

Health Policy Survey The 2024 CHCF California Health Policy Survey

Conducted in fall 2023, this survey collected Californian adults’ opinions and experiences on various health care topics, including mental health, medical debt, racial equity, and more.

California Healthline is a service of the California Health Care Foundation produced by KFF Health News, an editorially independent program of the KFF.

About Us
Contact Us
Editorial Policy
Privacy Policy
Staff
Republish Our Content
Email Sign-Up

Twitter
Facebook
RSS

Powered by WordPress VIP